BACKGROUND: Human immunodeficiency virus (HIV)-related mortality has decreased because of highly active antiretroviral therapy. As the life expectancy of HIV-infected patients has increased, the management of comorbid disease in such patients has become a more important concern. We examined the level of comfort self-reported by experts in HIV medicine with prescribing medications to HIV-infected patients for hyperlipidemia, diabetes, hypertension, and depression. METHODS: As part of a larger project (the Veterans Aging Cohort Study), physicians at infectious diseases (ID) clinics and physicians at general medical (GM) clinics were asked to complete a survey requesting information about demographic characteristics, training and certification received, and self-reported comfort with prescribing medications for patients with hyperlipidemia, diabetes, hypertension, and/or depression. Comfort was rated using a 5-point Likert scale, with scores of 4-5 classified as "comfortable." RESULTS: Of 150 attending physicians surveyed, 51 (34%) were ID certified, 33 (22%) were GM certified but practicing at an ID clinic, and 66 were GM certified and practicing at a GM clinic. Comorbid conditions were common among HIV-infected patients treated at the ID clinics (22% of these patients had hyperlipidemia, 17% had diabetes, 40% had hypertension, and 27% had depression). However, comfort with treating these conditions was less among physicians at the ID clinic. For example, comfort treating patients with hyperlipidemia was greater for GM-certified physicians at GM clinics than for GM-certified physicians and ID-certified physicians at ID clinics (98% vs. 73% and 71%, respectively; P < .0001 for trend). A similar pattern was seen for treating patients with diabetes and hypertension (P < .0001). Comfort with treating patients with depression was generally lower, particularly among physicians at ID clinics (P < .0001). CONCLUSIONS: We found that ID-certified physicians and GM-certified physicians at ID clinics reported less comfort prescribing medications for common comorbid conditions, compared with generalist physicians at GM clinics, despite a substantial prevalence of these conditions at the ID clinics. Methods are needed to increase physicians' level of comfort for prescribing treatment and/or to facilitate referral to other physicians for treatment.
BACKGROUND:Human immunodeficiency virus (HIV)-related mortality has decreased because of highly active antiretroviral therapy. As the life expectancy of HIV-infectedpatients has increased, the management of comorbid disease in such patients has become a more important concern. We examined the level of comfort self-reported by experts in HIV medicine with prescribing medications to HIV-infectedpatients for hyperlipidemia, diabetes, hypertension, and depression. METHODS: As part of a larger project (the Veterans Aging Cohort Study), physicians at infectious diseases (ID) clinics and physicians at general medical (GM) clinics were asked to complete a survey requesting information about demographic characteristics, training and certification received, and self-reported comfort with prescribing medications for patients with hyperlipidemia, diabetes, hypertension, and/or depression. Comfort was rated using a 5-point Likert scale, with scores of 4-5 classified as "comfortable." RESULTS: Of 150 attending physicians surveyed, 51 (34%) were ID certified, 33 (22%) were GM certified but practicing at an ID clinic, and 66 were GM certified and practicing at a GM clinic. Comorbid conditions were common among HIV-infectedpatients treated at the ID clinics (22% of these patients had hyperlipidemia, 17% had diabetes, 40% had hypertension, and 27% had depression). However, comfort with treating these conditions was less among physicians at the ID clinic. For example, comfort treating patients with hyperlipidemia was greater for GM-certified physicians at GM clinics than for GM-certified physicians and ID-certified physicians at ID clinics (98% vs. 73% and 71%, respectively; P < .0001 for trend). A similar pattern was seen for treating patients with diabetes and hypertension (P < .0001). Comfort with treating patients with depression was generally lower, particularly among physicians at ID clinics (P < .0001). CONCLUSIONS: We found that ID-certified physicians and GM-certified physicians at ID clinics reported less comfort prescribing medications for common comorbid conditions, compared with generalist physicians at GM clinics, despite a substantial prevalence of these conditions at the ID clinics. Methods are needed to increase physicians' level of comfort for prescribing treatment and/or to facilitate referral to other physicians for treatment.
Authors: Cynthia M Boyd; Christine S Ritchie; Edmond F Tipton; Stephanie A Studenski; Darryl Wieland Journal: Aging Clin Exp Res Date: 2008-06 Impact factor: 3.636
Authors: A Ben Appenheimer; Barbara Bokhour; D Keith McInnes; Kelly K Richardson; Andrew L Thurman; Brice F Beck; Mary Vaughan-Sarrazin; Steven M Asch; Amanda M Midboe; Thom Taylor; Kelly Dvorin; Allen L Gifford; Michael E Ohl Journal: Open Forum Infect Dis Date: 2017-02-03 Impact factor: 3.835
Authors: Corinne M Rhodes; Yuchiao Chang; Susan Regan; Daniel E Singer; Virginia A Triant Journal: Open Forum Infect Dis Date: 2017-01-31 Impact factor: 3.835
Authors: Claire E Kendall; Douglas G Manuel; Jaime Younger; William Hogg; Richard H Glazier; Monica Taljaard Journal: Ann Fam Med Date: 2015-09 Impact factor: 5.166
Authors: April D Kimmel; Erika G Martin; Hadiza Galadima; Rose S Bono; Ali Bonakdar Tehrani; John W Cyrus; Margaret Henderson; Kenneth A Freedberg; Alexander H Krist Journal: AIDS Care Date: 2016-05-13
Authors: Nwora Lance Okeke; Allison R Webel; Hayden B Bosworth; Angela Aifah; Gerald S Bloomfield; Emily W Choi; Sarah Gonzales; Sarah Hale; Corrilynn O Hileman; Virginie Lopez-Kidwell; Charles Muiruri; Megan Oakes; Julie Schexnayder; Valerie Smith; Rajesh Vedanthan; Chris T Longenecker Journal: Am Heart J Date: 2019-07-18 Impact factor: 4.749
Authors: Raphael J Landovitz; Katherine A Desmond; Jennifer L Gildner; Arleen A Leibowitz Journal: AIDS Patient Care STDS Date: 2016-09 Impact factor: 5.078